Medline Industries Recalls Nail Kits Due to Potential Sterility Issues in Wound Wash
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has voluntarily recalled over 8,700 nail kits because the included sterile saline wound wash may not meet required sterility assurance levels.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Medline Industries, LP has initiated a voluntary recall of its Medline Convenience Kits (Nail Kits) after identifying that the manufacturer of the sterile saline wound wash included in the kits may not have met the minimum sterility assurance levels required for sterile products. This Class II recall was initiated by the firm via letter on January 5, 2026.
Which Products Are Affected
The recall affects 8,773 units of the Medline Convenience Kits: NAIL KIT, specifically Model Number: DYKM1528. The affected products were distributed worldwide, including throughout the United States, the Bahamas, Bermuda, and the Cayman Islands.
The following lot numbers are included in this recall:
- 25BBO366
- 25ABI804
- 25ABF375
- 24JBL155
- 24IBG900
- 24FBT801
- 24FBC584
- 24DBB692
- 24BBL239
- 23KBO692
- 23IBT788
- 23HBJ026
- 23EBK780
- 23DBL149
- 23CBJ576
UDI-DI Information:
- Each: 10889942689927
- Case: 40889942689928
What You Should Do
Consumers and healthcare facilities should immediately check their inventory for the affected lot numbers listed above. If you possess recalled kits, you should follow the instructions provided in the notification letter sent by Medline Industries. For more information regarding the return or replacement process, contact Medline Industries, LP at their Northfield, Illinois headquarters.
Why This Matters
When medical products intended to be sterile do not meet sterility assurance levels, there is an increased risk of infection for patients. This recall ensures that potentially compromised wound wash components are removed from use to maintain patient safety.
Source
This information is sourced from the FDA under recall number Z-1434-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.